For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy ...

Current antiarrhythmic drugs for AF have limited ... and atrial remodeling. Class III drugs sotalol, dofetilide and ibutilide target reentry by prolonging the atrial effective refractory period ...

adverse events that were attributed to antiarrhythmic drug treatment included death from pulmonary toxic effects in 1 patient (0.5%) and nonfatal adverse events in 46 patients (21.6%). Among ...

However, the efficacy of antiarrhythmic agents has not been rigorously evaluated in patients with ARVC, and limited data are available to support such use of these drugs. The Multidisciplinary ...

Lignocaine is a class IB antiarrhythmic drug and is the first choice for VT. It is given intravenously in a dose of 1–3 mg/kg. For cardiac arrest, a 100 mg bolus is given, which may be repeated after ...

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions.